Evidence map›Paper›PMID 37938475›Full record

ArticleAdministration and policy in mental health2024

COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the Pandemic.

Vicki Fung, Julie H Levison, Anna Wilson, David Cheng, Cindy Chau, David Krane, Hao D Trieu, Kelly Irwin, Elizabeth Cella, Bruce Bird and 17 more

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Administration and policy in mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04726371 (Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04726371 nacompletednot on this map

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

TypeinterventionalSponsorMassachusetts General HospitalRan2020 to 2022Enrolled415ConditionsIntellectual Disability, Developmental Disability, Axis I Diagnosis, Mental IllnessArmsGeneric Best Practices, Tailored Best Practices
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 5 institutions in 1 country.

Vicki FungMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA. vfung@mgh.harvard.edu.ORCID 0000-0001-8078-5431
Julie H LevisonMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Anna WilsonMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
David ChengDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Cindy ChauMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
David KraneMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Hao D TrieuMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Kelly IrwinMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Elizabeth CellaVinfen Corporation, Cambridge, MA, USA.
Bruce BirdVinfen Corporation, Cambridge, MA, USA.
Kim ShellenbergerVinfen Corporation, Cambridge, MA, USA.
Paula SilvermanVinfen Corporation, Cambridge, MA, USA.
Joey BatsonVinfen Corporation, Cambridge, MA, USA.
Ahmed FathiVinfen Corporation, Cambridge, MA, USA.
Stefanie GamseVinfen Corporation, Cambridge, MA, USA.
Jessica WolfeVinfen Corporation, Cambridge, MA, USA.
Sibyl HollandVinfen Corporation, Cambridge, MA, USA.
Karen DonelanMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Ronita SamuelsMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Jessica E BeckerDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Kenneth A FreedbergMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Jean-Louise ReichmanNorth Suffolk Mental Health Association, Chelsea, MA, USA.
Terina KellerBay Cove Human Services, Boston, MA, USA.
Alexander C TsaiMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
John HsuMongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Brian G Skotko *Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.
Stephen Bartels *Mongan Institute, Massachusetts General Hospital, Harvard Medical School, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
Boston University · USHarvard University · USDepartment of Human Services · USMassachusetts General Hospital · USSuffolk University · US

Funding

Training in Child Health Services Research and Implementation ScienceT32HS000063 · AHRQ · CHILDREN'S HOSPITAL BOSTON · PI GARABEDIAN, LAURA FADEN, WALSH, KATHLEEN ELIZABETH · 1994 to 2024
$7.6M
AHRQ HHS T32 HS000063Patient-Centered Outcomes Research Institute COVID-2020C2-10803
6 · The paper itself

Abstract

This study examined COVID-19 infection and hospitalizations among people with serious mental illness who resided in residential care group homes in Massachusetts during the first year of the COVID-19 pandemic. The authors analyzed data on 2261 group home residents and COVID-19 data from the Massachusetts Department of Public Health. Outcomes included positive COVID-19 tests and COVID-19 hospitalizations March 1, 2020-June 30, 2020 (wave 1) and July 1, 2020-March 31, 2021 (wave 2). Associations between hazard of outcomes and resident and group home characteristics were estimated using multi-level Cox frailty models including home- and city-level frailties. Between March 2020 and March 2021, 182 (8%) residents tested positive for COVID-19, and 51 (2%) had a COVID-19 hospitalization. Compared with the Massachusetts population, group home residents had age-adjusted rate ratios of 3.0 (4.86 vs. 1.60 per 100) for COVID infection and 13.5 (1.99 vs. 0.15 per 100) for COVID hospitalizations during wave 1; during wave 2, the rate ratios were 0.5 (4.55 vs. 8.48 per 100) and 1.7 (0.69 vs. 0.40 per 100). In Cox models, residents in homes with more beds, higher staff-to-resident ratios, recent infections among staff and other residents, and in cities with high community transmission risk had greater hazard of COVID-19 infection. Policies and interventions that target group home-specific risks are needed to mitigate adverse communicable disease outcomes in this population.Clinical Trial Registration Number This study provides baseline (i.e., pre-randomization) data from a clinical trial study NCT04726371.

Indexed as

COVID-19Mental DisordersClinical Trials as TopicGroup HomesHumansMassachusettsNursing HomesPandemicsCongregate living environmentsCOVID-19Group homesSerious mental illness

Identifiers

PMID37938475
PMCPMC10872570
OpenAlexW4388493673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.